Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr-Jun;19(2):288-90.
doi: 10.4103/0972-2327.176864.

Necrotizing autoimmune myopathy

Sachin Suresh Babu  1 , Laxmi Khanna  1 , Ravindra Kumar Saran  1 , Gaurav Mittal  1 , Sudhir Peter  1 , Ivy Sebastian  1
Affiliations

Necrotizing autoimmune myopathy

Sachin Suresh Babu et al. Ann Indian Acad Neurol. 2016 Apr-Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI imaging — vastus lateralis, intermedius, and adductor muscles appeared bulky — altered signal intensity in the form of T2 and stir hyperintensity (edema sign)
Figure 2
Figure 2
H E SLIDE X 10 — showed necrotic muscle fibers without inflammatory infiltrate
Figure 3
Figure 3
Immunohistochemistry shows CD68 macrophage marker positive (brown) cells interspersed between myocytes
Figure 4
Figure 4
HLA typing — HLA 2 showed some overexpression on sarcolemmal membrane
See this image and copyright information in PMC

References

    1. García-Reynoso MJ, Veramendi-Espinoza LE, Ruiz-Garcia HJ. Ascending paresis as presentation of an unusual association between necrotising autoimmune myopathy and systemic lupus erythematosus. Rheumatol Clin. 2014;10:183–6. - PubMed
    1. Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015;72:996–1003. - PubMed
    1. Dalakas MC. Inflammatory muscle diseases: A critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010;10:346–52. - PubMed
    1. Santo JA, Garcia R, Barbosa B, Rebelo O, de Moura JP. Immune-mediated necrotizing myopathy: An often misdiagnosed entity. Eur J Case Rep Intern Med. 2015;2 doi:10.12890/2015_000164.
    1. Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series. Arthritis Care Res (Hoboken) 2010;62:1328–34. - PMC - PubMed